Anna Vilborg
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- RNA Research and Splicing
- RNA modifications and cancer
- RNA and protein synthesis mechanisms
- Genomics and Chromatin Dynamics
- Circular RNAs in diseases
Papers in
-
- RNA Research and Splicing 9
- CRISPR and Genetic Engineering 6
- RNA modifications and cancer 5
- RNA Interference and Gene Delivery 3
- RNA and protein synthesis mechanisms 2
- Genomics and Chromatin Dynamics 2
- Oncology 4
- Cancer-related Molecular Pathways 3
- Co-authors
- Joan A. Steitz (5 shared papers)Klas G. Wiman (7 shared papers)Therese A. Yario (2 shared papers)Margareta Wilhelm (3 shared papers)Maria C. Passarelli (2 shared papers)Cinzia Bersani (5 shared papers)Kazimierz T. Tycowski (1 shared paper)Valeria Yartseva (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Modern Pathology (1 paper)Cell Death and Disease (1 paper)FEBS Letters (1 paper)npj Genomic Medicine (1 paper)
- Partner nations
- United StatesSwedenIsrael
In The Last Decade
Anna Vilborg
14 papers receiving 740 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 264
- Molecular Biology 645
- Oncology 111
- Aging 6
- Immunology 48
Countries citing papers authored by Anna Vilborg
This map shows the geographic impact of Anna Vilborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Vilborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Vilborg more than expected).
Fields of papers citing papers by Anna Vilborg
This network shows the impact of papers produced by Anna Vilborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Vilborg. The network helps show where Anna Vilborg may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Vilborg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 195 | |
| 2 | 2015 | 132 | |
| 3 | 2017 | 85 | |
| 4 | 2009 | 77 | |
| 5 | 2010 | 59 | |
| 6 | 2014 | 53 | |
| 7 | 2016 | 32 | |
| 8 | 2011 | 27 | |
| 9 | 2008 | 20 | |
| 10 | 2018 | 15 | |
| 11 | 2016 | 14 | |
| 12 | 2015 | 13 | |
| 13 | 2020 | 12 | |
| 14 | 2012 | 7 |
About Anna Vilborg
Anna Vilborg is a scholar working on Molecular Biology, Oncology, Cancer Research, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 14 papers that have together received 741 indexed citations. Recurring topics across this work include RNA Research and Splicing (9 papers), CRISPR and Genetic Engineering (6 papers), RNA modifications and cancer (5 papers), Cancer-related Molecular Pathways (3 papers), RNA Interference and Gene Delivery (3 papers), Cancer Genomics and Diagnostics (2 papers), RNA and protein synthesis mechanisms (2 papers) and Genomics and Chromatin Dynamics (2 papers). The work is most often cited by research in Cancer Research (264 citations), Molecular Biology (645 citations), Oncology (111 citations), Aging (6 citations) and Immunology (48 citations). Anna Vilborg has collaborated with scholars based in United States, Sweden and Israel. Frequent co-authors include Joan A. Steitz, Klas G. Wiman, Therese A. Yario, Margareta Wilhelm, Maria C. Passarelli, Cinzia Bersani, Kazimierz T. Tycowski, Valeria Yartseva, Nara Lee and Nenad Šestan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Modern Pathology, Cell Death and Disease, FEBS Letters and npj Genomic Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.